Jenna E. Kay, M.D.
NPI 1760771380ActiveIndividual· Internal Medicine, Advanced Heart Failure and Transplant Cardiology· Portland, OR
Internal Medicine, Advanced Heart Failure and Transplant Cardiology (M.D.) in Portland, Oregon, trained at University of California, San Francisco School of Medicine (class of 2011). Their prescriptions cost Medicare Part D more than their services did: $7,910,861 for 4,594 claims, against $57,042 paid for services in 2024. Alnylam Pharmaceuticals Inc. was the largest of 3 companies reporting payments in 2025, $36,247 in all, mostly speaking and faculty fees.
Overview
| NPI | 1760771380 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | Apr 5, 2011 |
| Last updated in NPPES | Mar 19, 2024 |
| Certified by provider | Mar 19, 2024 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Advanced Heart Failure and Transplant Cardiology Primary | 207RA0001X | MD192910 | OR |
| Internal Medicine | 207R00000X | MD192910 | OR |
| Internal Medicine, Cardiovascular Disease | 207RC0000X | MD192910 | OR |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Advanced Heart Failure and Transplant Cardiology (OR) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 248 |
|---|---|
| Services billed | 701 across 25 procedure codes |
| Paid by Medicare | $57,042 |
Part D prescriptions in 2024
| Prescriptions (claims) | 4,594 · 10,142 30-day fills |
|---|---|
| Patients | 482 |
| Total drug cost | $7,910,861 |
| Generic share | 65% of claims |
Education and affiliations
| Medical school | University of California, San Francisco School of Medicine |
|---|---|
| Graduation year | 2011 |
| Medicare specialty | Advanced Heart Failure And Transplant Cardiology |
| Secondary specialties | Cardiovascular Disease (Cardiology) |
| Telehealth | Offers telehealth |
Medical groups
- Providence Health and Services OregonPortland, OR · 1,433 clinicians
- Providence Health and Services - OregonPortland, OR · 208 clinicians
Hospital affiliations
- Providence Milwaukie HospitalMilwaukie, OR
- Providence Portland Medical CenterPortland, OR
- Providence Seaside HospitalSeaside, OR
- Providence St Vincent Medical CenterPortland, OR
- Providence Willamette Falls Medical CenterOregon City, OR
Industry payments (Open Payments)
- 2025$36,247 · 28 payments from 3 companies
- 2024$61.17 · 2 payments from 2 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | $21,738 | 18 |
| Bridgebio Pharma, Inc. | $14,388 | 9 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $120.90 | 1 |
What the 2025 payments were for
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$34,433 · 12 payments
- Travel and Lodging$1,007 · 5 payments
- Food and Beverage$807.61 · 11 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in Portland
- 1548223381
- 1477732535
- 1447518923
- 1285741843
- 1285647669
- 1215203252
- 1154687622
- 1154663987
- 1861697682
- 1750547535
All Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in Oregon →